President Donald Trump’s executive order on May 12 instituting most-favored-nation (MFN) pricing of prescription drugs sought to ensure that Americans would pay no more than the lowest price charged in similar countries. Using an MFN model to set U.S. drug prices would have a considerable positive effect on American consumers, employers and governments. As pointed out in […]